Drug recall · June 15, 2022
Glucagen recall
Why: cGMP deviations: Temperature abuse
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Glucagen (glucagon) for injection, packaged in a 10-count box, (10 vials each containing 1 mg per vial), Rx only, MFG: Boehringer Mannheim, NDC 0597-0053-45
- Lots / codes
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
- Quantity
- 1 carton/10 vials per carton
- Company
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Distribution
- USA nationwide.
- Initiated
- April 13, 2022 · Voluntary: Firm initiated
- Classified
- June 9, 2022
- Reported
- June 15, 2022
- Ended
- November 30, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glucagon
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.